Your Article Summary
Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
Dendreon Coproration, 10/13/09
Dendreon Corporation announced that Ian Clark and Pedro Granadillo have been elected to the Company's Board of Directors. Mr. Clark is currently head of global product strategy and chief marketing officer at Roche, Pharma Division, and, beginning January, 2010, he will be chief executive officer and head of North American commercial operations at Genentech, a wholly–owned member of the Roche Group. Mr. Granadillo, now retired, was most recently senior vice president of global manufacturing and human resources at Eli Lilly & Company.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
New CEO announced for CAMH
Canadian Healthcare Technology, 11/20/09
Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
Mylan, 11/19/09
Storrer to Lead MEDecision
HealthDataManagement, 11/18/09
Article Search
Sponsor


See Latest Articles


